Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Live Updating

bigfish1972 Free

01/03/13 1:14 AM

Post #3

Re: #2: @threewheeler - 13:14 1/3/2013 HXBM Helix Biomedix,

Great, I'm tired of holding onto this thing, LOL. I should have had more patience, could have gotten sub-.20s easily as it turns out, but hey...still doubled my money. Probably more of a waste of time than anything.

Where did you see this today? I didn't see any news or filings. The last filing I see is their form 15 from yesterday. Thanks!

threewheeler Free

01/02/13 1:35 PM

Post #2

Re: #1: @bigfish1972 - So...anyone get those 299 shares today? Double

13:14 1/3/2013 HXBM Helix Biomedix, Inc. Common Stock HXBMD Helix Biomedix, Inc. NEW Common Stock 1-300 R/S **

bigfish1972 Free

09/11/12 7:46 PM

Post #1

So...anyone get those 299 shares today? Double your money at .30!

http://finance.yahoo.com/news/helix-biomedix-announces-plan-voluntary-131500190.html

Helix Biomedix, Inc. (HXBM)

Followers	0	Posters	2
Posts (Today)	0	Posts (Total)	3
Created	04/23/12	Type	Free
Moderators

Helix BioMedix, Inc. was founded in 1988 with the mission of developing and commercializing small proteins known as bioactive-peptides. We are headquartered in Bothell, Washington and shares of our common stock trade over-the-counter under the symbol “HXBM.OB”. We have developed a proprietary library containing a broad and diverse array of bioactive peptides. Our patent estate covers six distinct classes of peptides, comprising more than 100,000 unique peptide sequences. Our primary commercial objective is to out-license proprietary peptides to entities that possess sales, marketing and/or manufacturing expertise. Our peptides appear to have both pharmaceutical as well as non-pharmaceutical uses including broad-spectrum topical anti-infectives, wound healing agents, and cosmeceutical peptide ingredients.